The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

e-ESO Podcasts - A podcast by ESO - European School of Oncology

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Eman Aboelkheir, Alexandria University, Alexandria, Egypt